To reduce the effect of activating/silencing gene mutations on mTOR transcriptomic analysis, cell lines with cancer driving genomic alterations in PTEN, mTOR, AKT1, AKT2, AKT3, PI3KCA, TSC1, or TSC2 were excluded. This evidence concerns the gene TSC1 and cancer.